MSTR is currently trading at a significant discount—roughly 61% below where Wall Street analysts have set their average price target of $441. What does that math tell us? Simple: there's potentially 158% upside on the table. Here's the kicker though—analyst targets tend to be on the conservative side anyway. So when you're looking at that kind of gap between current price and consensus estimates, it's worth paying attention to whether the market is pricing in something the broader research community hasn't fully accounted for yet.